Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from glandular epithelial cells of the duodenum.
Biomarker and diagnostic research for duodenal adenocarcinoma has been reported in the published literature.
5 clinical trials registered, 2 recruiting. Interventions under study include procedural interventions, other interventions, drug therapy, and biologic therapy. Pipeline includes 1 PHASE2, 1 PHASE1, 2 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05810142](https://clinicaltrials.gov/study/NCT05810142) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:32 PM UTC
Clinical Study on Third-line Treatment of Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With Sindillimab |
— |
RenJi Hospital |
UNKNOWN |
[NCT02757859](https://clinicaltrials.gov/study/NCT02757859) | WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer | NA | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | UNKNOWN |
[NCT07328607](https://clinicaltrials.gov/study/NCT07328607) | Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy | NA | Minia University | RECRUITING |
[NCT05116072](https://clinicaltrials.gov/study/NCT05116072) | Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula | PHASE1 | University Hospital, Lille | UNKNOWN |
[NCT07282912](https://clinicaltrials.gov/study/NCT07282912) | Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels | PHASE2 | Yale University | RECRUITING |
85 publications have been identified in PubMed for duodenal adenocarcinoma. Research spans Case Report / Case Series (35%), Clinical Trial Publication (20%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 30 | 35% |
Clinical study results | 17 | 20% |
Disease patterns and progression | 16 | 19% |
Laboratory research | 12 | 14% |
Testing and diagnosis research | 5 | 6% |
Other research | 2 | 2% |
New treatment approaches | 2 | 2% |
Research summaries | 1 | 1% |
Krishnan SK (2026). [PMID: 42147504](https://pubmed.ncbi.nlm.nih.gov/42147504/). *Cureus*. [Case Report / Case Series]
Nappo G (2026). [PMID: 42154175](https://pubmed.ncbi.nlm.nih.gov/42154175/). *Updates Surg*. [Clinical Trial Publication]
Nemtarev AV (2026). [PMID: 40945407](https://pubmed.ncbi.nlm.nih.gov/40945407/). *Colloids Surf B Biointerfaces*. [Gene Therapy / Novel Therapeutics]
Ao J (2026). [PMID: 41800032](https://pubmed.ncbi.nlm.nih.gov/41800032/). *Frontiers in oncology*. [Basic Science / Preclinical]
Seckar TD (2026). [PMID: 41763535](https://pubmed.ncbi.nlm.nih.gov/41763535/). *The American journal of pathology*. [Basic Science / Preclinical]
Wu Y (2026). [PMID: 41563052](https://pubmed.ncbi.nlm.nih.gov/41563052/). *International journal of surgery (London, England)*. [Case Report / Case Series]
Tjandra D (2026). [PMID: 42029141](https://pubmed.ncbi.nlm.nih.gov/42029141/). *J Clin Gastroenterol*. [Diagnostic / Biomarker]
Li Y (2026). [PMID: 41557106](https://pubmed.ncbi.nlm.nih.gov/41557106/). *Discover oncology*. [Case Report / Case Series]
Morocho B (2026). [PMID: 41693301](https://pubmed.ncbi.nlm.nih.gov/41693301/). *Journal of surgical oncology*. [Clinical Trial Publication]
Balarajah V (2026). [PMID: 41895379](https://pubmed.ncbi.nlm.nih.gov/41895379/). *Hum Pathol*. [Diagnostic / Biomarker]
AI-curated news mentioning duodenal adenocarcinoma
Updated Aug 4, 2026
A recent publication explores synchronous medullary carcinoma of the pancreas alongside non-ampullary duodenal adenocarcinoma. This study contributes to the understanding of these rare cancer types and their potential interrelation.